Meet 3 men who’ve been on the front lines of HIV treatments for decades
Johnson & Johnson’s Brian Woodfall, M.D., was working at a Vancouver clinic in the mid-1990s. That’s where he met Tiko Kerr, who became one of the first patients to take the company’s HIV medicines—and has thrived to this day. For National AIDS Awareness Month, watch as Kerr, Dr. Woodfall and fellow researcher Joss J. De Wet, M.D., reflect on how those treatments have saved lives and continue to evolve, in this moving video.
Johnson & Johnson’s Patrick Stephens explains how innovative technology using ultrasonic acoustic pressure waves has made the treatment of certain types of cardiovascular disease easier for doctors and safer for patients.
This chronic inflammatory disease causes flareups that make it difficult to breathe. Learn about the two types of asthma, common triggers and how Johnson & Johnson is developing approaches that may lead to better treatments.
The company made the prestigious list for the 24th consecutive year, thanks to its dedication to innovation and social responsibility, among other criteria.